Atrial fibrillation may increase risk for dementia
Large Kaiser Permanente study finds a 13% greater risk of being diagnosed with dementia after a diagnosis of atrial fibrillation, with stronger associations seen in younger, healthier people.
Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
State-level educational quality linked to risk of dementia
People attending schools in states with higher state-level educational quality are less likely to develop dementia in late life, according to a new Kaiser Permanente analysis published in JAMA Neurology.
Cancer diagnosis hastens aging in women
Kaiser Permanente study finds postmenopausal women with cancer report a greater decline in physical function than women who have not had cancer.
Benefit of dialysis unclear for older people with chronic kidney disease and heart failure
Kaiser Permanente study highlights the need for more research on the best patient-centered care for people managing both conditions.
Higher risk of dementia for older adults living with HIV
A study reviewing 16 years of patient data found nearly double the rate of dementia among people with HIV compared with those without HIV. The rate of dementia decreased over time for both groups but remained higher for those with HIV, reported research published in the journal AIDS.
Gaining insight into medically complex patients
New Kaiser Permanente study aims to help providers improve the health of patients most likely to sustain high medical costs, frequently use the emergency department, or need to be hospitalized.
Kaiser Permanente to study statins’ effect on Alzheimer’s disease and related dementias
The potential for statins — a widely prescribed class of cholesterol-lowering medication — to reduce the risk of Alzheimer’s disease and related dementias will be explored in a 4-year study led by Division of Research investigator Catherine Schaefer, PhD.
Telehealth appointments improve follow-up care in patients with heart failure
Kaiser Permanente study is the first to compare early telehealth approach to early in-person follow-up to prevent hospital readmissions.
New virtual, innovative clinical trial for adults at high risk for respiratory illnesses
Kaiser Permanente researchers will see if a drug used to reduce risk of heart attack and stroke can also prevent or reduce complications from viral respiratory illnesses in older adults with heart disease.
5 Questions for . . . Stephen Van Den Eeden
Research scientist Stephen Van Den Eeden, PhD, is a co-founder of the California Men's Health Study, one of the largest and longest-running cohort studies of men in the world.